Consistent with the association between high DNAm scores and T2-high asthma, we observed overexpression of canonical T2 genes implicated in the pathways or directly targeted by current biologic therapeutics, including IL1RL1, CCR3, and IL5RA10,53,54. This evidence concerns the gene IL1RL1 and asthma.